Skip to main content

Home/ Health affairs/ Group items tagged operations

Rss Feed Group items tagged

pharmacybiz

Independent Pharmacies on the Rise in England: Trends & Opportunities - 0 views

  •  
    The pharmacy market in England has seen a significant transformation in recent years, driven by a trend of large-scale disposals by corporate operators. Jonathan Board, Director - Pharmacy, Christie & Co, has told Pharmacy Business that several corporate operators are looking to sell off their marginal or non-performing assets while independent operators are eager to acquire and enhance businesses further. Due to their scale, corporate operators are compelled to adopt a 'one size fits all' approach. However, Jonathan believes this puts them at a disadvantage compared to many independent operators who are better positioned to meet local patient and community needs, delivering a more personalised approach to patient engagement, and a variety of other services "As such, where corporate disposals have taken place, there has been a steady stream of independent operators eager to take over and develop the businesses further," he said.
pharmacybiz

4 Important Post-Operative Advice You Should Follow - 0 views

  •  
    After you've had surgery, it's normal to feel a little anxious about the recovery process. But there are some things you can do to help make sure everything goes smoothly. Here are four important pieces of postoperative advice that will help you heal quickly and avoid any complications. Follow these tips and you'll be on your way to a full recovery in no time. FOLLOW YOUR DOCTOR'S ORDERS No matter how minor the operation, following your doctor's orders after surgery is essential to a speedy and successful recovery. Doing the right things like following a balanced diet, taking the recommended amount of medications, and avoiding strenuous activity can help minimize complications, reduce pain, and speed up healing. Furthermore, consistent follow-up visits with your doctor and timely scheduling of any necessary tests ensure that any post-operative problems are addressed in their early stages when they are easiest to treat. The people behind www.alamoplasticsurgery.com note that failing to take your doctor's instructions seriously can have a significant impact on your overall recovery time, jeopardize the long-term outcome of your treatment, or even lead to additional procedures. To ensure you make the most out of your surgery experience - listen to what your doctor has to say! GET PLENTY OF REST Getting a full night's rest after the surgery is key to a successful recovery. During recovery, your body is working overtime to heal and repair itself, so by getting plenty of rest, you'll give it the best opportunity to do this. Not only that - research has shown that getting lots of sleep may help support important bodily functions related to healing such as immune response and inflammation control. Listen to your doctor's advice post-surgery and make sure you get enough sleep - providing your body with the downtime it needs will ultimately speed up the healing process and help ensure you get back on your feet soon. When it comes to recovering from surgery,
pharmacybiz

Operation Opal Cracks Down on UK Shoplifting Epidemic | 152 Offenders Identified - 0 views

  •  
    Police chiefs are reporting significant progress in their battle against shoplifting epidemic, thanks to the newly established centralised police unit - Operation Opal. Launched earlier this year, Operation Opal is the national intelligence unit focused on serious organised acquisitive crime. The team collects evidence from CCTV footage, crime reports and other sources from all 43 police forces in England and Wales. Police chiefs believe that unit is starting to "turn the tide" against prolific shoplifters who are used by organised crime groups to steal goods en masse, The Times reported. The Operation Opal team has already identified 152 prolific people involved in organised retail crime within the first three months of the operation. Among those identified was Alexandru-Iulian Dima, a 25-year-old Romanian man who arrived in the UK last year.
pharmacybiz

MHRA Win Against Illegal Meds :£5M Seized | Operation Pangea - 0 views

  •  
    The MHRA's Criminal Enforcement Unit (CEU), working with other law enforcement partners, has seized more than two million "illegally traded medicines" this year, with a total value of £5 million. The products confiscated in the UK were prescription-only medicines including anti-depressants, pain medication and human growth hormones. The MHRA launched an initiative, Operation Pangea, 15 years ago to combat "illegal internet trade in medical" products. Andy Morling, the Deputy Director of Criminal Enforcement of MHRA, spoke about Operation Pangea's 15-year anniversary. "Fifteen years ago, the MHRA started Operation Pangea, combining our knowledge and resources with those of international partners to disrupt and bring to justice the criminal gangs responsible for selling medicines illegally and causing harm around the world.
pharmacybiz

Stone Pharmacy sold to East Lancashire operator - 0 views

  •  
    Stone Pharmacy in Barnsley, South Yorkshire has been sold to existing operator, Livesey Healthcare, which owns another pharmacy in East Lancashire for an undisclosed price. Stone Pharmacy is a well-established, 100-hour community pharmacy that is run under full management with a locum Pharmacist, and dispenses an average of 22,000 items per month. The business adjoins Garland House surgery in the South Yorkshire village of Darfield, which is circa six miles east of Barnsley and circa 14 miles north of Sheffield. The pharmacy has been owned by experienced operators, Khuram Akhtar and Mohammed Ali, trading as MEDS2U Ltd, for the last seven years, and was recently brought to market to allow the pair to pursue new ventures both in and out of community pharmacy. Khuram Akhtar, former owner of Stone Pharmacy, commented: "The business at Stone Pharmacy has been a fantastic enterprise for many years for us, with limited competition and a position central to the local community we have always enjoyed the support of the nearby population and are pleased that it is now in the hands of experienced operators who can build on that foundation with the expansion of new services.
pharmacybiz

Pharmacy Trends 2023: Shifts, Challenges, and Solutions - 0 views

  •  
    In its response to a Freedom of Information Request (FOI), the NHS Business Services Authority (NHSBSA) has confirmed a net decrease of 101 pharmacies in England - with 371 closures and 270 new contracts. Meanwhile, the General Pharmaceutical Council data projected a drop of 43 registered pharmacies in England, Wales, and Scotland for the year ending March 31, 2023, compared to the preceding period. The data, released by business advisor Christie & Co in its annual pharmacy market review on Sept. 5, revealed a total of 14,328 pharmacies across all four UK country regions as of March 31, 2023, indicating a 0.3 per cent decrease from the previous year. Corporate operators experienced a net reduction of 249 pharmacies, while the total number of independent operators remained consistent with 2022. According to the study, the corporate sector saw the most substantial shift, with a 13.7 per cent reduction in businesses operating 300 or more pharmacies. Following closely, groups managing 11 to 15 pharmacies experienced a 5.6 per cent decrease. Christie & Co attributed this shift in group size to operators acquiring additional pharmacies through corporate disposal opportunities throughout the year.
pharmacybiz

Superdrug announces pay rise for newly qualified pharmacists - 0 views

  •  
    Superdrug has announced a pay increase for newly qualified pharmacists, in a move that will see wages rise to £50,000 - ensuring that Superdrug Pharmacists continue to receive the strongest renumeration package on the high street today. Superdrug is also enhancing its patient experience and operational structure, with the introduction of a new role of Pharmacy Team Leader to selected pharmacy stores. Pharmacy Team Leaders will be dispenser trained and provide a clear line of accountability for day-to-day dispensary activity including adhering to legal and clinical frameworks whilst supporting, coaching, and developing a high-performing pharmacy team. The role also allows Superdrug to offer a clear line of progression for talented Pharmacy Dispensers and Technicians who want to do more in their career and recognises the valuable contribution Pharmacy Dispensers & Technicians play in community pharmacy. In addition, the appointment of two new Heads of Pharmacy Operations sees the high street retailer driving and improving Superdrug's pharmacy performance to offer the best possible care for patients. Craig Watt, Pharmacist and previously Area Manager, has been appointed to Head of Pharmacy Operations North and will be responsible for the operation of Superdrug's central distribution hub serving its e-pharmacy and Online Dr team.
pharmacybiz

How pharmacies can navigate financial and operational challenges - 0 views

  •  
    A harsh funding regime that hasn't adapted to changing macroeconomic realities means the viability of large parts of the pharmacy sector is at risk unless the model changes. Very simply, across the sector, revenue has remained largely fixed while costs have increased significantly, making it impossible for many pharmacies to sustain their business models. The sector has seen the closure of more than 1,500 community pharmacies since 2015, with 700 of these closures occurring since 2021. Larger pharmacy operators such as Lloyds, Boots, and Rowlands have seen the biggest decline in numbers, with smaller businesses operating between one and five pharmacies now accounting for almost 50% of the sector. Despite rising inflation and business costs, the NHS pharmacy funding model has remained fixed. Over the period of the current Community Pharmacy Contractual Framework (CPCF) - 2019-2024 - pharmacies have experienced a 30% real terms cut in core funding leading to an annual shortfall of over £750 million, equivalent to £67,000 per pharmacy in England. The current CPCF is due to end in 2024, and there is still no arrangement in place for future funding, leading to delayed and inefficient spending decisions and hampering the ability of the sector to plan and attract much-needed investment.
pharmacybiz

NHS Contracts Breach:Impact on Pharmacies and Patient Access - 0 views

  •  
    There is clear evidence that the majority of distance selling pharmacies are operating in breach of their NHS contracts, and a failure to properly regulate 'pseudo' distance selling pharmacies is leading to local pharmacy closures, the Company Chemists' Association has reported. According to the CCA's recent findings, 72 per cent of DSPs dispense over 50 per cent of their prescriptions to patients within a single postcode area within 10 miles of the pharmacy. "Operating within constrained geographical regions, pseudo-DSPs achieve reduced overheads and operational costs by focusing on localised marketing and medicine delivery. They compete against local brick-and-mortar pharmacies, causing them to lose vital trade," the CCA claimed, based on its recent survey - The Impact of Pseudo Distance Selling Pharmacies. "As per their terms of service, DSPs are obligated to provide prescription delivery nationwide, extending beyond local patients," said the CCA, adding that the financial savings resulting from the lack of patient access are balanced by the necessity to function on a national scale.
pharmacybiz

Hallo Healthcare Exits Hospital Pharmacy Sites 2024 - PDA Offers Crucial Support to Pha... - 0 views

  •  
    Hallo Healthcare has announced its decision to exit from its hospital pharmacy sites, currently operated by LloydsPharmacy Healthcare Services (LP HCS Limited), which primarily provides outpatient services. Pharmacists and their teams at its 64 pharmacy sites were informed on Monday, 19 August 2024, about the company's plans to withdraw from this sector. The Pharmacists' Defence Association (PDA), the recognised trade union representing pharmacists at these sites, was also notified. The association has assured its support for members impacted by the decision, although it noted that the process of branch transfers could take several months. "It is expected to be several months before all such branch transfers are agreed and undertaken," the PDA said. The association noted that contracts to provide such services "do change hands periodically with some hospital outpatient departments (OPDs) operated by pharmacy multiples and others operated by hospital-owned subsidiaries" and highlighted its experience in supporting pharmacists when employers change in this way. PDA Union Director Paul Day is hopeful that there will be no job losses in outpatient services and that all pharmacists will be able to continue in their current roles.
pharmacybiz

Novartis:Operating profit grow amid spin off Sandoz generics - 0 views

  •  
    Novartis on Wednesday (February 1) predicted that core operating income would grow in a "mid single digit" percentage range in 2023 following stagnation last year, as the Swiss drugmaker prepares to spin off its Sandoz generics business. Full-year core operating income was broadly flat at $16.7 billion, it said in a statement, coming in slightly below market expectations of $16.8 billion. Adjusted for overall negative currency effects, group sales in 2022 advanced 4 per cent to $50.5 billion as gains from heart failure drug Entresto and multiple sclerosis (MS) drug Kesimpta were partly offset by competition from cheap generic copies of established MS drug Gilenya. Novartis said it was on track to spin off its generics unit Sandoz in the second half of the year as part of its effort to sharpen its focus on its patented prescription medicines. Analysts have welcomed a programme unveiled in 2022 to trim costs and cut 8,000 jobs and plans to focus on fewer therapy areas and drug technologies. But the market has been underwhelmed by prospects for medium-term growth from new drugs.
pharmacybiz

Rogue Chemist Jailed: Inside the Prescription Drug Scandal - 0 views

  •  
    A drug dealer who was operating as an "unlicensed chemist" and selling prescription drugs online has been jailed for six years, according to Essex Police. The convict, identified as 49-year-old Christopher Depp, aka David Jones, was supplying a range of drugs from his home to "vulnerable people" using the postal service, local police revealed on Friday (February 16). Police conducted a search operation at his address in Wood Street, Chelmsford, in July last year and found more than 50,000 pills and tablets of varying types, stashed in toolboxes and spaces around the property. To process the large-scale sale and shipping of controlled drugs across the UK, Depp had set up a room in his property as an office space. He promoted the sale of medications through various social media platforms and messaging applications, and accepted payment from his large customer base using "fraudulently obtained" bank accounts.
healthcare_jobs

Practice Management Challenges of Covid-19 | HospitalRecruiting.com - 0 views

  •  
    "The COVID-19 pandemic is confronting medical practices with unique operational challenges. Some practices have turned to telemedicine. Some providers are finding it difficult to continue operating at all, with sweeping cancellations of elective procedures and discouragement of in-person office appointments. Economic fallout due to the virus's effects on virtually every person, everywhere, is another concern facing all aspects of all healthcare systems..."
pharmacybiz

Numan deploys Titan software to drive efficiency - 0 views

  •  
    To increase efficiency savings, digital men's health provider Numan has joined forces with Invatech Health to deploy the health tech company's cutting-edge software Titan. Launched in early 2019, Numan provides medication for 175,000 patients via its Cardiff-based fulfilment operation. A team of its clinicians create personalised treatment plans for the most common male health concerns. In a statement, Invatech said its Titan software could deliver 20 per cent efficiency savings for Numan whilst supporting the company's ambitious growth plans with improved safety and scalability in processing medications. The new partnership also comes alongside 100 new contracts with community pharmacies around the UK. Andrew Caple, director of Pharmacy Operations at of Numan, said: "Our findings show that three quarters of men will not visit a doctor when they have a health concern, and we therefore recognise that the online market provides a great opportunity to tackle these problems.
pharmacybiz

RP Healthcare Sells Hammersmith Pharmacy in West London - 0 views

  •  
    RP Healthcare, a multi-operator, has sold Hammersmith pharmacy in West London to an independent pharmacist for an undisclosed amount. "Mariam Moshref, owner of Fulham Pharmacy, together with her twin brothers, Arya and Jaan Moshref, purchased Hammersmith Pharmacy from Ravi Patel of RP Healthcare," Christie and Co, who handled the sale, said in a statement. This pharmacy operates during standard hours, handling an average of 5,920 items per month, the statement added. Refurbished in 2018, the pharmacy is located on Fulham Palace Road, W6, near Charing Cross Hospital and Hammersmith Underground station. RP Healthcare placed the pharmacy on the market as a strategic move to divest from the area.
pharmacybiz

Ravindra Limaye:OBE honour for contribution to health sector - 0 views

  •  
    Wockhardt UK managing director Ravindra Limaye has been chosen for honorary British awards given to foreign nationals. Limaye gets the Order of the British Empire (OBE) honour for his contribution to health, particularly during the Covid-19 pandemic. The honours were announced on Thursday (13). Limaye has been the chief executive of the UK arm of the Mumbai-based pharma and biotech company Wockhardt since 2019. He previously worked for another Indian pharma company Biocon, overseeing its global commercial operations. He led the company's entry into global biosimilar markets and spearheaded its operations in the US.
pharmacybiz

Titanverse: Revolutionizing Pharmacy Management - 0 views

  •  
    Bristol-based Titan PMR, a technology firm specialising in PMR systems for community pharmacies, is set to roll out an innovative platform named 'Titanverse,' that it claims will redefine pharmacy management, offering comprehensive solutions extending beyond prescription management. This new platform takes a versatile approach, efficiently managing all facets of pharmacy operations, from high-level management down to daily tasks, according to top company officials. "Our aim is to reshape pharmacies into genuine health hubs, providing advanced services and harnessing state-of-the-art technologies," said Tariq Muhammad, CEO of Titan PMR. "Titanverse, our latest offering, is positioned to ignite this transformation, revolutionising clinical services in the same way its predecessor revolutionised dispensing. With Titanverse, we have the vehicle to drive this vision forward, placing pharmacies at the forefront of primary care in the future." Titanverse adopts a Teams approach, catering to pharmacies with multiple locations or specific focuses. It furnishes real-time analytics and employs a color-coded rating system for swift performance evaluation. Moreover, the platform eases operations by enabling task delegation, encompassing clinical checks and dispensing, all while backing private services with adaptable templates and workflows.
pharmacybiz

David Wright: HRA Pharma's former CEO joins Ceuta Group - 0 views

  •  
    Ceuta Group, a global brand building business providing end-to-end outsourcing services in the health and wellness industry has appointed David Wright as a non-executive board director. With extensive experience of leading global consumer healthcare companies, David joins Ceuta Group following five years as CEO/President of global pharmaceutical company, HRA Pharma and six years as Global Head of Boehringer Ingelheim's consumer business. During his time at HRA Pharma and Boehringer Ingelheim GmBH, David led both companies through substantial organisational and strategy re-design which led to sustainable growth and profitability. The company said: "David has a strong belief that combining the right structure, operational priorities and processes, with a strong focus on company culture, are critical factors in building successful businesses. This approach saw him lead a period of transformation at HRA Pharma resulting in the company's successful acquisition by Perrigo Company plc." David will take an active role on the Ceuta Group Board supporting and building the company's strategic vision and priorities. He will also help shape the company's growth plans on an operational level to ensure Ceuta Group continues to meet client's needs today and into the future.
pharmacybiz

PSNC launches Pharmacy Pressures Survey 2023 - 0 views

  •  
    The Pharmaceutical Services Negotiating Committee (PSNC) has launched Pharmacy Pressures Survey 2023 to make case against the 'unprecedented financial and operational challenges' faced by the community pharmacies in England. The Committee has urged those working in or owns a community pharmacy to 'take part' in the survey. "The survey results will be critical to help us to show Government and the NHS how difficult things now are for pharmacies, and to persuade them to take action. We will be using the results in our negotiations, in our conversations with MPs, Ministers and in national media work as part of the joint #saveourpharmacies campaign," said PSNC. The Pharmacy Pressures Survey is once again comprised of two surveys to give insight into both financial and operational pressures. Together with the other national pharmacy organisations PSNC are working both to show policy makers the severity of the problems and to lobby for Government and NHS action to ease the pressures.
pharmacybiz

Roger Scarlett-Smith steps down as head of STADA UK - 0 views

  •  
    In a mutual agreement with the STADA board, Roger Scarlett-Smith has stepped down from his role as head of UK. The company has assigned the responsibility of UK operation to Rudolf Bär with current responsibilities as cluster head for Mid-Sized European Markets. Scarlett-Smith joined STADA in October 2018 to lead the UK operation upon the retirement of Dieno George. Prior to this, he had enjoyed an illustrious career in the Consumer Healthcare sector, largely with GlaxoSmithKline, for which he held positions including as President North America, President EMEA and Head of Global Categories. Under his leadership, the STADA UK business has grown sales by 50 per cent and profitability has more than doubled. He has reshaped the business to improve efficiency. There has been a marked acceleration of product innovation including key line extensions to the Zoflora disinfectant range as well as the introduction of a salmeterol and fluticasone inhaler in the Rx respiratory sector. Meanwhile, T+R has developed a fine reputation regionally, being voted number 1 regional company last year and winning many national industry awards.
1 - 20 of 210 Next › Last »
Showing 20 items per page